{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:01:01Z","timestamp":1781211661739,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vph.2025.107552","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:38:12Z","timestamp":1760542692000},"page":"107552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites"],"prefix":"10.1016","volume":"161","author":[{"given":"Kevin","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.orcp.2023.06.001","article-title":"Lipoxins and their relationship with inflammation-associated diseases. A systematic review","volume":"17","author":"Serna","year":"2023","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.vph.2025.107552_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: managing the fire within","volume":"9","author":"Chiurchi\u00f9","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2025.107552_bb0015","series-title":"Seminars in immunopathology","first-page":"627","article-title":"Resolution of inflammation: from basic concepts to clinical application","volume":"Vol. 41","author":"Neurath","year":"2019"},{"key":"10.1016\/j.vph.2025.107552_bb0020","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fphar.2018.01273","article-title":"Lipoxin and Resolvin receptors transducing the resolution of inflammation in cardiovascular disease","volume":"9","author":"Pirault","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imcb.12206","article-title":"Efferocytosis: molecular mechanisms and pathophysiological perspectives","volume":"97","author":"Gheibi Hayat","year":"2019","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.vph.2025.107552_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/549691","article-title":"PPAR\u03b3 and the innate immune system mediate the resolution of inflammation","author":"Croasdell","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.vph.2025.107552_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2017.12.008","article-title":"Prostaglandin E2 as a regulator of immunity to pathogens","volume":"185","author":"Mart\u00ednez-Col\u00f3n","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vph.2025.107552_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/327568","article-title":"Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs","author":"Medeiros","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.vph.2025.107552_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00095-21","article-title":"Roles of eicosanoids in regulating inflammation and neutrophil migration as an innate host response to bacterial infections","volume":"89","author":"Sheppe","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vph.2025.107552_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4049\/jimmunol.174.2.595","article-title":"Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase a and exchange protein directly activated by cAMP-1","volume":"174","author":"Aronoff","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1753425916684934","article-title":"Efferocytosis-induced prostaglandin E2 production impairs alveolar macrophage effector functions during Streptococcus pneumoniae infection","volume":"23","author":"Salina","year":"2017","journal-title":"Innate Immun."},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41423-020-00541-3","article-title":"Macrophages and the maintenance of homeostasis","volume":"18","author":"Mosser","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.vph.2025.107552_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2567.2006.02402.x","article-title":"Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells","volume":"119","author":"Son","year":"2006","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.vph.2025.107552_bb0075","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4049\/jimmunol.1900201","article-title":"Prostaglandin E2 inhibits the ability of neutrophils to kill Listeria monocytogenes","volume":"202","author":"Pitts","year":"2019","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/iid3.295","article-title":"Human mast cells exhibit an individualized pattern of antimicrobial responses","volume":"8","author":"Garcia-Rodriguez","year":"2020","journal-title":"Immun. Inflamm. Dis."},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1189\/jlb.4MR0617-227RR","article-title":"Group a streptococcal pharyngitis: immune responses involved in bacterial clearance and GAS-associated immunopathologies","volume":"103","author":"Soderholm","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0090","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.1202932","article-title":"Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent streptococcus pyogenes","volume":"190","author":"Soares","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0095","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.1000838","article-title":"Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes","volume":"185","author":"Goldmann","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/nu14030503","article-title":"Carvacrol suppresses inflammatory biomarkers production by Lipoteichoic acid- and peptidoglycan-stimulated human tonsil epithelial cells","volume":"14","author":"Wijesundara","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2567.2004.01810.x","article-title":"Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis","volume":"111","author":"Walker","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.vph.2025.107552_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111378","article-title":"Postoperative natural killer cell dysfunction: the prime suspect in the case of metastasis following curative cancer surgery","volume":"22","author":"Market","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2025.107552_bb0115","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22647","article-title":"A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis","volume":"2","author":"Ma","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.vph.2025.107552_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002486","article-title":"Human herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma","volume":"8","author":"Dupuy","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.vph.2025.107552_bb0125","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/IAI.01412-07","article-title":"Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells","volume":"76","author":"Woolard","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vph.2025.107552_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2015.03.083","article-title":"Lipoxins and aspirin-triggered lipoxins in resolution of inflammation","volume":"760","author":"Romano","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.vph.2025.107552_bb0135","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.3390\/molecules28135032","article-title":"Specialized pro-resolving lipid mediators: endogenous roles and pharmacological activities in infections","volume":"28","author":"Rasquel-Oliveira","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.vph.2025.107552_bb0140","first-page":"181","article-title":"Lipoxins: nature\u2019s way to resolve inflammation","volume":"8","author":"Chandrasekharan","year":"2015","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283163","article-title":"Aspirin modulates production of pro-inflammatory and pro-resolving mediators in endothelial cells","volume":"18","author":"Rood","year":"2023","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vph.2025.107552_bb0150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41574-023-00822-7","article-title":"The G protein-coupled oestrogen receptor GPER in health and disease: an update","volume":"19","author":"Prossnitz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.vph.2025.107552_bb0155","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/biom13091410","article-title":"The role of G protein-coupled estrogen receptor (GPER) in vascular pathology and physiology","volume":"13","author":"Xu","year":"2023","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.vph.2025.107552_bb0160","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1096\/fj.11-187658","article-title":"Lipoxin A4 is a novel estrogen receptor modulator","volume":"25","author":"Russell","year":"2011","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.vph.2025.107552_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","article-title":"Therapeutic potential of Lipoxin A4 in chronic inflammation: focus on cardiometabolic disease","volume":"3","author":"Fu","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.vph.2025.107552_bb0170","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3389\/fmicb.2018.01961","article-title":"Inflammatory and pro-resolving lipids in trypanosomatid infections: a key to understanding parasite control","volume":"9","author":"L\u00f3pez-Mu\u00f1oz","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.vph.2025.107552_bb0175","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3389\/fphar.2019.00891","article-title":"Regulation of apoptotic cell clearance during resolution of inflammation","volume":"10","author":"Arienti","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.vph.2025.107552_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038384","article-title":"SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses","volume":"7","author":"McBerry","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vph.2025.107552_bb0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.vph.2025.107552_bb0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12079-021-00630-6","article-title":"A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action","volume":"16","author":"Biringer","year":"2022","journal-title":"J. Cell. Commun. Signal."},{"key":"10.1016\/j.vph.2025.107552_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","article-title":"Lipid mediators in inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.vph.2025.107552_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00011-014-0792-7","article-title":"Chemerin\/chemR23 axis in inflammation onset and resolution","volume":"64","author":"Mariani","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.vph.2025.107552_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174527","article-title":"Resolvin D1, therapeutic target in acute respiratory distress syndrome","volume":"911","author":"Molaei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"40","key":"10.1016\/j.vph.2025.107552_bb0215","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","article-title":"Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway","volume":"111","author":"Fredman","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0220","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1096\/fj.10-175687","article-title":"Leukotriene B4\/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2\/ALX and are counterregulated by lipoxin A4 and resolvin E1","volume":"25","author":"Wan","year":"2011","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0225","first-page":"2570","article-title":"Aspirin-triggered lipoxin A4 attenuates lipopolysaccharide-induced acute lung injury by inhibiting activation of mitogen-activated protein kinases and NF-\u03baB in mice","volume":"11","author":"Liu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.vph.2025.107552_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115437","article-title":"Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators","volume":"209","author":"Yasmeen","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0235","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1615\/CritRevImmunol.2018026750","article-title":"Function of pro-resolving lipid mediator Resolvin E1 in type 2 diabetes","volume":"38","author":"Sima","year":"2018","journal-title":"Crit. Rev. Immunol."},{"issue":"7268","key":"10.1016\/j.vph.2025.107552_bb0240","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"issue":"7395","key":"10.1016\/j.vph.2025.107552_bb0245","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"issue":"52","key":"10.1016\/j.vph.2025.107552_bb0250","doi-asserted-by":"crossref","first-page":"43079","DOI":"10.1074\/jbc.M509796200","article-title":"The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering","volume":"280","author":"Ariel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2025.107552_bb0255","article-title":"Protectins: their biosynthesis, metabolism and structure-functions","volume":"206","author":"Hansen","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0260","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","article-title":"Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)"},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0265","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/IAI.01131-15","article-title":"Maresin 1 biosynthesis and proresolving anti-infective functions with human-localized aggressive periodontitis leukocytes","volume":"84","author":"Wang","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vph.2025.107552_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.acc.2024.11.008","article-title":"Preeclampsia and eclampsia: the role of hemolytic protozoan iron","volume":"125","author":"Roe","year":"2025","journal-title":"Adv. Clin. Chem."},{"issue":"6","key":"10.1016\/j.vph.2025.107552_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100377","article-title":"Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy","volume":"64","author":"Stephenson","year":"2023","journal-title":"J. Lipid Res."},{"issue":"24","key":"10.1016\/j.vph.2025.107552_bb0280","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.3390\/ijms21249628","article-title":"The role of arachidonic and linoleic acid derivatives in pathological pregnancies and the human reproduction process","volume":"21","author":"Szczuko","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","article-title":"Eicosanoids in preeclampsia","volume":"70","author":"Walsh","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0290","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/aogs.14505","article-title":"Metabolic profiling of pregnancies complicated by preeclampsia: a longitudinal study","volume":"102","author":"Skytte","year":"2023","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0295","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/HYPERTENSIONAHA.112.197897","article-title":"Preeclampsia is associated with compromised maternal synthesis of long-chain polyunsaturated fatty acids, leading to offspring deficiency","volume":"60","author":"Mackay","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2025.107552_bb0300","first-page":"227","article-title":"Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators","volume":"341","author":"Chiang","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.vph.2025.107552_bb0305","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.12728","article-title":"Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid","volume":"12","author":"Undas","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.vph.2025.107552_bb0310","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1734-1140(10)70306-6","article-title":"Transcellular biosynthesis of eicosanoids","volume":"62","author":"Sala","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.vph.2025.107552_bb0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2017.00261","article-title":"Aspirin: the mechanism of action revisited in the context of pregnancy complications","volume":"8","author":"Cadavid","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13206","article-title":"Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma","volume":"83","author":"Oliveira Perucci","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.vph.2025.107552_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.959239","article-title":"Focusing on the role of secretin\/adhesion (class B) G protein-coupled receptors in placental development and preeclampsia","volume":"10","author":"Yin","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.48095\/cccg2021297","article-title":"Maternal and neonatal outcomes in pregnancies complicated by eclampsia - analysis of cases from 2008-2018","volume":"86","author":"Andrea","year":"2021","journal-title":"Ceska Gynekol."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0335","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3390\/ijerph20042994","article-title":"Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition","volume":"20","author":"Chang","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.vph.2025.107552_bb0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/nu15010140","article-title":"African American women with Cardiometabolic complications of pregnancy have decreased serum abundance of specialized pro-resolving lipid mediators and endocannabinoids","volume":"15","author":"Maner-Smith","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0345","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.vph.2025.107552_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2023.111132","article-title":"Pre-eclampsia and eclampsia pathogenesis utilizes iron released by a hemolytic protozoan parasite","volume":"178","author":"Roe","year":"2023","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.vph.2025.107552_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1150054","article-title":"Hemoglobin uptake and utilization by human protozoan parasites: a review","volume":"13","author":"Reyes-L\u00f3pez","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.vph.2025.107552_bb0360","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbapap.2017.01.006","article-title":"Diverse structural approaches to haem appropriation by pathogenic bacteria","volume":"1865","author":"Hare","year":"2017","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15698\/mic2023.05.796","article-title":"Infinity war: trichomonas vaginalis and interactions with host immune response","volume":"10","author":"Bongiorni Galego","year":"2023","journal-title":"Microb. Cell"},{"issue":"2","key":"10.1016\/j.vph.2025.107552_bb0370","doi-asserted-by":"crossref","first-page":"133.e1","DOI":"10.1016\/j.ajog.2006.08.033","article-title":"Modulation of vaginal immune response among pregnant women with bacterial vaginosis by trichomonas vaginalis, chlamydia trachomatis, Neisseria gonorrhoeae, and yeast","volume":"196","author":"Cauci","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0375","first-page":"1191","article-title":"A disproportionate increase in IL-1\u03b2 over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth","volume":"190","author":"Genc","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.vph.2025.107552_bb0380","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2006.08.035","article-title":"Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy","volume":"196","author":"Simhan","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.vph.2025.107552_bb0385","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.olq.0000243618.71908.95","article-title":"Systemic immune response to trichomonas vaginalis infection during pregnancy","volume":"34","author":"Anderson","year":"2007","journal-title":"Sex. Transm. Dis."},{"issue":"5","key":"10.1016\/j.vph.2025.107552_bb0390","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.vph.2025.107552_bb0395","article-title":"Omega-3 polyunsaturated fatty acids in critical illness: anti-inflammatory, proresolving, or both?","volume":"5987082","author":"Molfino","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6526","key":"10.1016\/j.vph.2025.107552_bb0400","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.aba9001","article-title":"GPER1 is required to protect fetal health from maternal inflammation","volume":"371","author":"Harding","year":"2021","journal-title":"Science"},{"issue":"6220","key":"10.1016\/j.vph.2025.107552_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.vph.2025.107552_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao1680","article-title":"Type I interferons instigate fetal demise after Zika virus infection","volume":"3","author":"Yockey","year":"2018","journal-title":"Sci. Immunol."},{"issue":"6449","key":"10.1016\/j.vph.2025.107552_bb0415","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.aaw7733","article-title":"IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise","volume":"365","author":"Buchrieser","year":"2019","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.vph.2025.107552_bb0420","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vph.2025.107552_bb0425","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00436-013-3444-x","article-title":"Protection of vascular endothelium by aspirin in a murine model of chronic Chagas\u2019 disease","volume":"112","author":"Molina-Berr\u00edos","year":"2013","journal-title":"Parasitol. Res."},{"issue":"10","key":"10.1016\/j.vph.2025.107552_bb0430","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1128\/AAC.02752-14","article-title":"Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response","volume":"58","author":"Malvezi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.vph.2025.107552_bb0435","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jiac.2024.07.006","article-title":"Are secondary bacterial pneumonia mortalities increased because of insufficient pro-resolving mediators?","volume":"30","author":"Roe","year":"2024","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.vph.2025.107552_bb0440","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2125.2005.02572.x","article-title":"Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection","volume":"61","author":"Todros","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2025.107552_bb0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1756-3305-7-167","article-title":"Lack of association between toxoplasma gondii infection and hypertensive disorders in pregnancy: a case-control study in a northern Mexican population","volume":"7","author":"Alvarado-Esquivel","year":"2014","journal-title":"Parasit. Vectors"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:03:11Z","timestamp":1781208191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":89,"alternative-id":["S1537189125000916"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107552","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-eclampsia with inflammatory and pro-resolving mediator fluctuations - contributions from hemolytic protozoan parasites","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107552"}}